EP4285929
Samsett HBV-meðferð
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
19.12.2019EP published:
8.10.2025EP application number:
23190149.7
EP translation filed:
29.12.2025Grant published:
14.1.2026EPO information:
European Patent Register
Max expiry date:
18.12.2039Expiry date:
18.12.2026Next due date:
31.12.2026
Title in English:
COMBINATION HBV THERAPYLanguage of the patent:
English
Timeline
Today
19.12.2019EP application
8.10.2025EP Publication
29.12.2025Translation submitted
14.1.2026Registration published
18.12.2026Expires
Owner
Name:
Humabs Biomed SAAddress:
Via dei Gaggini, 3, 6500 Bellinzona, CH
Name:
VIR Biotechnology, Inc.Address:
1800 Owens Street Suite 900, San Francisco, CA 94158, US
Inventor
Name:
BAKARDJIEV, ANNAAddress:
San Francisco, California, US
Name:
PANG, PHILLIPAddress:
San Francisco, California, US
Name:
CORTI, DAVIDEAddress:
Bellinzona, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862782896 PDate:
20.12.2018Country:
US
Classification
Categories:
A61K 31/713, A61P 31/20, A61K 39/42, A61K 31/52, A61K 31/67, A61K 45/06, C07K 16/08
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 15.12.2025
Expires: 18.12.2026
Payer: Árnason Faktor ehf.